The impact of crystal phase transition on the hardness and structure of kidney stones
Urolithiasis - 2024
Tóm tắt
Calcium oxalate kidney stones, the most prevalent type of kidney stones, undergo a multi-step process of crystal nucleation, growth, aggregation, and secondary transition. The secondary transition has been rather overlooked, and thus, the effects on the disease and the underlying mechanism remain unclear. Here, we show, by periodic micro-CT images of human kidney stones in an ex vivo incubation experiment, that the growth of porous aggregates of calcium oxalate dihydrate (COD) crystals triggers the hardening of the kidney stones that causes difficulty in lithotripsy of kidney stone disease in the secondary transition. This hardening was caused by the internal nucleation and growth of precise calcium oxalate monohydrate (COM) crystals from isolated urine in which the calcium oxalate concentrations decreased by the growth of COD in closed grain boundaries of COD aggregate kidney stones. Reducing the calcium oxalate concentrations in urine is regarded as a typical approach for avoiding the recurrence. However, our results revealed that the decrease of the concentrations in closed microenvironments conversely promotes the transition of the COD aggregates into hard COM aggregates. We anticipate that the suppression of the secondary transition has the potential to manage the deterioration of kidney stone disease.
Từ khóa
Tài liệu tham khảo
LeGeros RZ (2001) Formation and transformation of calcium phosphates: relevance to vascular calcification. Z Kardiol 90:116–124. https://doi.org/10.1007/s003920170032
Gong N, Shangguan J, Liu X et al (2008) Immunolocalization of matrix proteins in nacre lamellae and their in vivo effects on aragonitic tablet growth. J Struct Biol 164:33–40. https://doi.org/10.1016/j.jsb.2008.05.009
Veis A, Dorvee JR (2013) Biomineralization mechanisms: a new paradigm for crystal nucleation in organic matrices. Calcif Tissue Int 93:307–315. https://doi.org/10.1007/s00223-012-9678-2
Yamashita I, Hayashi J, Hara M (2004) Bio-template synthesis of uniform CdSe nanoparticles using cage-shaped protein, apoferritin. Chem Lett 33:1158–1159. https://doi.org/10.1246/cl.2004.1158
Sugawara A, Nishimura T, Yamamoto Y et al (2006) Self-organization of oriented calcium carbonate/polymer composites: effects of a matrix peptide isolated from the exoskeleton of a crayfish. Angew Chemie - Int Ed 45:2876–2879. https://doi.org/10.1002/anie.200503800
Khan SR, Pearle MS, Robertson WG et al (2016) Kidney stones. Nat Rev Dis Prim 2:16008–16057. https://doi.org/10.1038/nrdp.2016.8
Sivaguru M, Saw JJ, Wilson EM et al (2021) Human kidney stones: a natural record of universal biomineralization. Nat Rev Urol 18:404–432. https://doi.org/10.1038/s41585-021-00469-x
Tostivint IN, Araman RG, Castiglione V et al (2022) How the diagnosis and the management of genetic renal phosphate leak impact the life of kidney stone formers? Urolithiasis 50:319–331. https://doi.org/10.1007/s00240-022-01316-3
Maruyama M, Tanaka Y, Momma K et al (2023) Evidence for solution-mediated phase transitions in kidney stones: Phase Transition exacerbates kidney Stone Disease. Cryst Growth Des 23:4285–4293. https://doi.org/10.1021/acs.cgd.3c00108
Pak CYC (1998) Kidney stones. Lancet 351:1797–1801. https://doi.org/10.1016/S0140-6736(98)01295-1
Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12:e86–96. https://doi.org/10.3909/riu0459
Saitoh H, DESCRIPTIONS OF URINE IN THE HIPPOCRATIC COLLECTION (2006) Japanese J Urol 97:10–19. https://doi.org/10.5980/jpnjurol1989.97.10
Boyce WH (1968) Organic matrix of human urinary concretions. Am J Med 45:673–683. https://doi.org/10.1016/0002-9343(68)90203-9
Warpehoski MA, Buscemi PJ, Osborn DC et al (1981) Distribution of organic matrix in calcium oxalate renal calculi. Calcif Tissue Int 33:211–222. https://doi.org/10.1007/BF02409440
Coe FL, Evan A, Worcester E (2005) Science in medicine kidney stone disease. J Clin Investig 115:2598–2608. https://doi.org/10.1172/JCI26662.2598
Khan SR (2006) Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 34:86–91. https://doi.org/10.1007/s00240-005-0016-2
Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ (2007) The role of urinary kidney stone inhibitors and promoters in the pathogenesis of Calcium containing Renal stones. EAU-EBU Updat Ser 5:126–136. https://doi.org/10.1016/j.eeus.2007.03.002
Alelign T, Petros B (2018) Kidney Stone Disease: an update on current concepts. https://doi.org/10.1155/2018/3068365. Adv Urol 2018:
Sivaguru M, Saw JJ, Williams JC et al (2018) Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep 8:13731. https://doi.org/10.1038/s41598-018-31890-9
Grases F, Costa-Bauzá A, García-Ferragut L (1998) Biopathological crystallization: a general view about the mechanisms of renal stone formation. Adv Colloid Interface Sci 74:169–194. https://doi.org/10.1016/S0001-8686(97)00041-9
Maruyama M, Sawada KP, Tanaka Y et al (2023) Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones. PLoS ONE 18:1–15. https://doi.org/10.1371/journal.pone.0282743
Heijnen WMM, Van Duijneveldt FB (1984) The theoretical growth morphology of calcium oxalate dihydrate. J Cryst Growth 67:324–336. https://doi.org/10.1016/0022-0248(84)90192-1
Chien YC, Masica DL, Gray JJ et al (2009) Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning. J Biol Chem 284:23491–23501. https://doi.org/10.1074/jbc.M109.021899
Momma K, Izumi F (2011) VESTA 3 for three-dimensional visualization of crystal, volumetric and morphology data. J Appl Crystallogr 44:1272–1276. https://doi.org/10.1107/S0021889811038970
Zarse CA, McAteer JA, Sommer AJ et al (2004) Nondestructive analysis of urinary calculi using micro computed tomography. BMC Urol 4:1–8. https://doi.org/10.1186/1471-2490-4-15
Tajiri R, Fujita T (2013) Observation methods of hard and soft animal tissues by grinding specimens impregnated with resin. Taxa. Proc Japan Soc Syst Zool 35:24–34. https://doi.org/10.19004/taxa.35.0_24
Selvaraju R, Raja A, Thiruppathi G (2012) FT-Raman spectral analysis of human urinary stones. Spectrochim Acta - Part Mol Biomol Spectrosc 99:205–210. https://doi.org/10.1016/j.saa.2012.09.004
Tanaka Y, Maruyama M, Okada A et al (2021) Multicolor imaging of calcium – binding proteins in human kidney stones for elucidating the effects of proteins on crystal growth. Sci Rep 11:16841–16841. https://doi.org/10.1038/s41598-021-95782-1
Khan SR, Hackett RL (1986) Identification of urinary stone and sediment crystals by scanning electron microscopy and X-ray microanalysis. J Urol 135:818–825. https://doi.org/10.1016/S0022-5347(17)45868-X
Cloutier J, Villa L, Traxer O, Daudon M (2015) Kidney stone analysis: give me your stone, I will tell you who you are! World J Urol 33:157–169. https://doi.org/10.1007/s00345-014-1444-9
Bazin D, Leroy C, Tielens F et al (2016) Hyperoxaluria is related to whewellite and hypercalciuria to weddellite: what happens when crystalline conversion occurs? Comptes Rendus Chim 19:1492–1503. https://doi.org/10.1016/j.crci.2015.12.011
Jacob DE, Grohe B, Geßner M et al (2013) Kidney stones in primary hyperoxaluria: New lessons Learnt. PLoS ONE 8:e70617–70625. https://doi.org/10.1371/journal.pone.0070617
Williams JC, Worcester E, Lingeman JE (2017) What can the microstructure of stones tell us? Urolithiasis 45:19–25. https://doi.org/10.1007/s00240-016-0944-z
Williams JC, Lingeman JE, Daudon M, Bazin D (2022) Using micro computed tomographic imaging for analyzing kidney stones. Comptes Rendus Chim 25:61–72. https://doi.org/10.5802/crchim.89
Momma K, Ikeda T, Nishikubo K et al (2011) New silica clathrate minerals that are isostructural with natural gas hydrates. Nat Commun 2:196–202. https://doi.org/10.1038/ncomms1196
Streit J, Tran-Ho LC, Königsberger E (1998) Solubility of the three calcium oxalate hydrates in sodium chloride solutions and urine-like liquors. Monatshefte fur Chemie 129:1225–1236. https://doi.org/10.1007/PL00010134
Baumann JM, Casella R (2019) Prevention of Calcium Nephrolithiasis: the influence of Diuresis on Calcium Oxalate crystallization in urine. Adv Prev Med 2019:1–8. https://doi.org/10.1155/2019/3234867
Ivan VM (2003) Crystal Growth for beginners: fundamentals of Nucleation, Crystal Growth, and Epitaxy, 2nd edn. World Scientific
Maruyama M, Yoshikawa HY, Takano K et al (2023) Solution-mediated phase transition of pharmaceutical compounds: case studies of acetaminophen and aspirin. J Cryst Growth 602:126990–126998. https://doi.org/10.1016/j.jcrysgro.2022.126990
Dorian HH, Rez P, Drach GW (1996) Evidence for aggregation in Oxalate Stone formation: Atomic Force and low voltage scanning Electron Microscopy. J Urol 156:1833–1837. https://doi.org/10.1016/S0022-5347(01)65547-2
Sandersius S, Rez P (2007) Morphology of crystals in calcium oxalate monohydrate kidney stones. Urol Res 35:287–293. https://doi.org/10.1007/s00240-007-0115-3
Michibata U, Maruyama M, Tanaka Y et al (2024) Calcium phosphate controls nucleation and growth of calcium oxalate crystal phases in kidney stones. Biomed Res Febr 20th 2024 accepted
Heimbach D, Munver R, Zhong P et al (2000) Acoustic and mechanical properties of artificial stones in comparison to natural kidney stones. J Urol 164:537–544. https://doi.org/10.1016/S0022-5347(05)67419-8